Clinical Trial: A Study of Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma

U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07324629) titled 'A Study of Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma' on Dec. 11, 2025.

Brief Summary: The goal of this clinical trial is to learn if drug Sac-TMT works to treat Thymic Carcinoma. It will also learn about the safety of Sac-TMT. The main questions it aims to answer are:

* How effective is drug Sac-TMT in treating Thymic Carcinoma?

* What adverse events (AEs) do participants have when taking drug Sac-TMT?

Participants will:

* Progress after at least one platinum-based chemotherapy treatment.

* Take drug Sac-TMT every 2 weeks.

* Take tumor response assessments every 6 weeks.

Stud...